The tumor microenvironment is a complex ecosystem of malignant and nonmalignant cells and extracellular proteins that work together to enhance tumor progression. We identified a mechanism in which adjacent nonmalignant epithelium enhances invasion of squamous cell carcinoma, thereby expanding the tumor microenvironment to include cancer-associated keratinocytes.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489914 | PMC |
| http://dx.doi.org/10.1080/23723556.2021.1933329 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mindin/spondin-2 regulates fibroblast subpopulations through distinct Src family kinases during fibrogenesis.
JCI Insight
December 2024
Center for Inflammation and Tissue Homeostasis, Institute for Stem Cell Science and Regenerative Medicine, Bangalore, India.
Fibrosis results from excessive extracellular matrix (ECM) deposition, causing tissue stiffening and organ dysfunction. Activated fibroblasts, central to fibrosis, exhibit increased migration, proliferation, contraction, and ECM production. However, it remains unclear if the same fibroblast performs all of the processes that fall under the umbrella term of "activation".
View Article and Find Full Text PDFChondroitin sulfate proteoglycan 4 increases invasion of recessive dystrophic epidermolysis bullosa-associated cutaneous squamous cell carcinoma by modifying transforming growth factor-β signalling.
Br J Dermatol
December 2024
Division of Blood and Marrow Transplant and Cellular Therapy, Department of Pediatrics, Medical School, University of Minnesota, MN,USA.
Background: Recessive dystrophic epidermolysis bullosa (RDEB) is a rare genetic skin-blistering disorder that often progresses to metastatic cutaneous squamous cell carcinoma (cSCC) at chronic wound sites. Chondroitin sulfate proteoglycan 4 (CSPG4) is a cell-surface proteoglycan that is an oncoantigen in multiple malignancies, where it modulates oncogenic signalling, drives epithelial-to-mesenchymal transition (EMT) and enables cell motility.
Objectives: To evaluate CSPG4 expression and function in RDEB cSCC.
Evaluation of BH3 mimetics as a combination therapy with irradiation in head and neck squamous cell carcinoma.
Biomed Pharmacother
June 2024
Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki 00014, Finland; Translational Immunology Research Program (TRIMM), University of Helsinki, Helsinki 00014, Finland; Cancer and Translational Medicine Research Unit, University of Oulu, Oulu 90014, Finland; Medical Research Center, Oulu University Hospital, Oulu 90220, Finland; Department of Pathology, Helsinki University Hospital (HUS), Helsinki 00029, Finland.
Introduction: Head and neck squamous cell carcinoma (HNSCC) is a common cancer with a five-year survival rate around 60%, indicating a need for new treatments. BH3 mimetics are small molecules that inhibit anti-apoptotic Bcl-2 family proteins, resulting in apoptosis induction.
Methods: We performed a high-throughput screen using a Myogel matrix to identify the synergy between irradiation and the novel BH3 mimetics A-1155463, A-1331852, and navitoclax in 12 HNSCC cell lines, normal (NOF) and cancer-associated fibroblasts (CAF), and dysplastic keratinocytes (ODA).
Genetic Studies of Actinic Keratosis Development: Where Are We Now?
Ann Dermatol
December 2023
Genomic Medicine Institute (GMI), Medical Research Center, Seoul National University, Seoul, Korea.
Article Synopsis
- - Actinic keratosis (AK) is a precancerous skin condition linked to UV light exposure and characterized by atypical skin cells, with a risk of progressing to cutaneous squamous cell carcinoma (CSCC).
- - Factors like genetic mutations and underlying health conditions such as diabetes and psoriasis contribute to the development of AK, and patients may also be at risk for other cancers.
- - Treatments for AK include methods like cryosurgery and topical therapies, while research is ongoing to uncover the genetic mechanisms behind its development and progression to CSCC.
The development of in vitro organotypic 3D vulvar models to study tumor-stroma interaction and drug efficacy.
Cell Oncol (Dordr)
June 2024
Department of Dermatology, Leiden University Medical Center, Leiden, 2333 ZA, The Netherlands.
Background: Vulvar squamous cell carcinoma (VSCC) is a rare disease with a poor prognosis. To date, there's no proper in vitro modeling system for VSCC to study its pathogenesis or for drug evaluation.
Methods: We established healthy vulvar (HV)- and VSCC-like 3D full thickness models (FTMs) to observe the tumor-stroma interaction and their applicability for chemotherapeutic efficacy examination.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!